Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR

116.2  -0.1 (-0.09%)

Fundamental Rating

6

Overall BIM gets a fundamental rating of 6 out of 10. We evaluated BIM against 54 industry peers in the Health Care Equipment & Supplies industry. BIM has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. BIM has a decent growth rate and is not valued too expensively. These ratings could make BIM a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BIM was profitable.
In the past year BIM had a positive cash flow from operations.
In the past 5 years BIM has always been profitable.
Each year in the past 5 years BIM had a positive operating cash flow.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

With an excellent Return On Assets value of 11.22%, BIM belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
BIM has a Return On Equity of 15.40%. This is amongst the best in the industry. BIM outperforms 87.04% of its industry peers.
The Return On Invested Capital of BIM (13.93%) is better than 92.59% of its industry peers.
Industry RankSector Rank
ROA 11.22%
ROE 15.4%
ROIC 13.93%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 11.01%, BIM is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
BIM's Profit Margin has been stable in the last couple of years.
BIM's Operating Margin of 14.91% is fine compared to the rest of the industry. BIM outperforms 79.63% of its industry peers.
In the last couple of years the Operating Margin of BIM has remained more or less at the same level.
BIM's Gross Margin of 55.73% is in line compared to the rest of the industry. BIM outperforms 51.85% of its industry peers.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
Industry RankSector Rank
OM 14.91%
PM (TTM) 11.01%
GM 55.73%
OM growth 3Y-13.96%
OM growth 5Y1.31%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BIM is creating value.
BIM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

BIM has an Altman-Z score of 7.19. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
BIM has a Altman-Z score of 7.19. This is amongst the best in the industry. BIM outperforms 96.30% of its industry peers.
BIM has a debt to FCF ratio of 1.53. This is a very positive value and a sign of high solvency as it would only need 1.53 years to pay back of all of its debts.
BIM has a Debt to FCF ratio of 1.53. This is amongst the best in the industry. BIM outperforms 94.44% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that BIM is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.08, BIM belongs to the best of the industry, outperforming 87.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Altman-Z 7.19
ROIC/WACC1.81
WACC7.71%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

BIM has a Current Ratio of 2.20. This indicates that BIM is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.20, BIM is doing good in the industry, outperforming 68.52% of the companies in the same industry.
BIM has a Quick Ratio of 1.29. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
BIM has a better Quick ratio (1.29) than 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.29
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

BIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.42%, which is quite impressive.
The Earnings Per Share has been growing by 10.91% on average over the past years. This is quite good.
Looking at the last year, BIM shows a very strong growth in Revenue. The Revenue has grown by 60.06%.
BIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.27% yearly.
EPS 1Y (TTM)81.42%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%120.99%
Revenue 1Y (TTM)60.06%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%

3.2 Future

BIM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.88% yearly.
Based on estimates for the next years, BIM will show a small growth in Revenue. The Revenue will grow by 3.88% on average per year.
EPS Next Y19.22%
EPS Next 2Y16.35%
EPS Next 3Y16.68%
EPS Next 5Y14.88%
Revenue Next Year7.85%
Revenue Next 2Y7.79%
Revenue Next 3Y8.07%
Revenue Next 5Y3.88%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

BIM is valuated quite expensively with a Price/Earnings ratio of 30.10.
Based on the Price/Earnings ratio, BIM is valued a bit cheaper than 72.22% of the companies in the same industry.
When comparing the Price/Earnings ratio of BIM to the average of the S&P500 Index (28.89), we can say BIM is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 25.25, the valuation of BIM can be described as expensive.
Based on the Price/Forward Earnings ratio, BIM is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.98, BIM is valued at the same level.
Industry RankSector Rank
PE 30.1
Fwd PE 25.25
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BIM's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BIM is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.78
EV/EBITDA N/A
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BIM may justify a higher PE ratio.
A more expensive valuation may be justified as BIM's earnings are expected to grow with 16.68% in the coming years.
PEG (NY)1.57
PEG (5Y)2.76
EPS Next 2Y16.35%
EPS Next 3Y16.68%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.80%, BIM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.15, BIM pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, BIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.8%

5.2 History

The dividend of BIM is nicely growing with an annual growth rate of 20.02%!
Dividend Growth(5Y)20.02%
Div Incr Years0
Div Non Decr Years6
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

15.47% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP15.47%
EPS Next 2Y16.35%
EPS Next 3Y16.68%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (3/27/2025, 11:48:43 AM)

116.2

-0.1 (-0.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-07 2025-03-07/bmo
Earnings (Next)09-03 2025-09-03
Inst Owners20.96%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap13.75B
Analysts76.84
Price Target126.23 (8.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.8%
Yearly Dividend0.85
Dividend Growth(5Y)20.02%
DP15.47%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.87%
PT rev (3m)3.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)0.84%
Valuation
Industry RankSector Rank
PE 30.1
Fwd PE 25.25
P/S 2.34
P/FCF 42.78
P/OCF 20.61
P/B 3.27
P/tB 4.61
EV/EBITDA N/A
EPS(TTM)3.86
EY3.32%
EPS(NY)4.6
Fwd EY3.96%
FCF(TTM)2.72
FCFY2.34%
OCF(TTM)5.64
OCFY4.85%
SpS49.69
BVpS35.53
TBVpS25.2
PEG (NY)1.57
PEG (5Y)2.76
Profitability
Industry RankSector Rank
ROA 11.22%
ROE 15.4%
ROCE 18.92%
ROIC 13.93%
ROICexc 15.42%
ROICexgc 21.79%
OM 14.91%
PM (TTM) 11.01%
GM 55.73%
FCFM 5.47%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-13.96%
OM growth 5Y1.31%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 5.88%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 49.65%
Current Ratio 2.2
Quick Ratio 1.29
Altman-Z 7.19
F-Score8
WACC7.71%
ROIC/WACC1.81
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)81.42%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%120.99%
EPS Next Y19.22%
EPS Next 2Y16.35%
EPS Next 3Y16.68%
EPS Next 5Y14.88%
Revenue 1Y (TTM)60.06%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
Revenue Next Year7.85%
Revenue Next 2Y7.79%
Revenue Next 3Y8.07%
Revenue Next 5Y3.88%
EBIT growth 1Y99.8%
EBIT growth 3Y-9.11%
EBIT growth 5Y9.7%
EBIT Next Year62.07%
EBIT Next 3Y27.39%
EBIT Next 5Y22.36%
FCF growth 1Y200.19%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y49.82%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%